Fish oil triglycerides

(Omegaven®)

Fish oil triglycerides

Drug updated on 3/28/2024

Dosage FormInjection (intravenous: 5 g/50 mL, 10 g/100 mL)
Drug ClassFatty acids
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PANC).

Summary
This AI-generated content is provided without warranty and may be inaccurate or outdated; it should be used only as a research starting point, with no liability accepted for reliance on it. Learn more.

  • Fish oil triglycerides (Omegaven) are indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PANC).
  • A network meta-analysis found that fish oil intravenous lipid emulsions, such as Omegaven, significantly reduced infection risk compared to other types of lipid emulsions. It also showed substantial reductions in hospital length of stay.
  • Another randomized controlled trial revealed that supplementation with omega-3 fatty acids like those found in Omegaven led to a significant increase in serum levels of brain-derived neurotrophic factor (BDNF), which could have potential implications for neurological health.
  • The benefits observed from the use of fish oil triglycerides were consistent across different patient populations and subgroups according to these studies. However, more research may be needed to confirm these findings across broader demographics.
  • These conclusions come from three systematic reviews/meta-analyses on the effects and benefits associated with the use of fish oil triglycerides or similar compounds.
  • One document was retracted due to inconsistencies discovered during an investigation following allegations raised by a third party; therefore its findings should not be considered reliable information about Omegaven's effectiveness or safety profile.